These findings identify the FGF21-MAPK1 axis as a critical regulatory node linking ketone body accumulation to hepatic lipid metabolism disorders, and suggest that modulation of this pathway may offer therapeutic potential. This evidence concerns the gene MAPK1 and Disorder of lipid metabolism.